Sandhya Balasubramanian

Medicine · Health Sciences

10h-index430citations33works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(9), Entrepreneurship Studies and Influences(4), DNA Repair Mechanisms(4), Bioinformatics and Genomic Networks(4), T-cell and B-cell Immunology(3)

Publications33 total

Transcriptional profiling refines DLBCL classification and identifies subtypes with distinct therapeutic vulnerabilities
Blood·2025
A Comparative Analysis of Individual Readers and an Autonomous Deep-Learning-Based Algorithm for Assessing Total Metabolic Tumor Volume from Positron Emission Tomography/Computed Tomography Scans
Blood·2024
Patients’ voices matter: Translating pretreatment patient-reported outcomes into high and low health-related quality of life provides a new clinical aspect on prognosis and survival in patients with previously untreated diffuse large B‐cell lymphoma.
Journal of Clinical Oncology·2024
Multiple Myeloma Disease Model to Predict PFS Outcomes across Lines of Therapy, an Analysis Based on Commpass Observational Study
Blood·2023Open Access
Plasma Circulating Tumor DNA (ctDNA) as an Alternative to Tissue DNA for Genotyping of DLBCL: Results from the POLARIX Study
Blood·2023· 3 cited
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Nature Communications·2023· 3 citedOpen Access
P1244: AN AUTOMATED QUANTIFICATION ALGORITHM FOR EVALUATING TOTAL METABOLIC TUMOR VOLUME IN PATIENTS WITH FDG-AVID LYMPHOMAS USING A DEEP LEARNING MODEL
HemaSphere·2023Open Access
Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.
Journal of Clinical Oncology·2023· 4 cited
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Nature Communications·2023· 86 citedOpen Access
Characterizing Diffuse Large B Cell Lymphoma (DLBCL) Disease Biology Features and Survival Outcomes By Patient Racial Groups Using Real World Data
Blood·2022
Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.
Journal of Clinical Oncology·2022· 3 cited
Author response: Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered region
2022Open Access
Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered region
2021Open Access
Dissecting the mechanism of RIF1 in maintaining DNA replication-associated genome stability
2021Open Access
Adoption of Mobile ERP in Educational Environment
International Journal of Enterprise Information Systems·2020· 15 cited
Entrepreneurial Orientation
2020· 6 cited
Abstract 2035: Listen to the patients: Assessing the prognostic value of pre-treatment health-related quality of life in 1L DLBCL patients
Cancer Research·2020
PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification
The Journal of Experimental Medicine·2020· 10 citedOpen Access
Pdap1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification
2020Open Access
Does university entrepreneurial orientation matter? Evidence from university performance
Strategic Entrepreneurship Journal·2020· 31 cited
page 1 of 2Next →

Frequent Co-authors

Natalia Maltsev(8), Yanwen Jiang(7), Bingqing Xie(7), T. Conrad Gilliam(7), Dinanath Sulakhe(6), Joseph N. Paulson(5), Andrew Taylor(5), Jinbo Xu(5), Daniela Börnigen(5), Gady Agam(5), Ali Rahjouei(5), Michela Di Virgilio(5), Sheng Wang(4), Utpal Dave(4), Devakumar Sundaravinayagam(4), Alex F. Herrera(4), Fabrice Jardin(4), Georg Lenz(4), Franck Morschhauser(4), Bo Feng(3)